Basic echocardiographic features of patients with latent left ventricular outflow tract obstruction without left

Hiroaki Semba1, Hitoshi Sawada, Tokuhisa Uejima

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.

Insights

Latent left ventricular outflow tract obstruction (L-LVOTO) can occur in patients without left ventricular hypertrophy (LVH). The LVOT ratio is a key predictor for identifying L-LVOTO in non-LVH patients undergoing dobutamine stress echocardiography.

Area of Science:

  • Cardiology
  • Echocardiography
  • Medical Diagnostics

Background:

  • Left ventricular outflow tract obstruction (LVOTO) is often associated with hypertrophic cardiomyopathy (HCM) or left ventricular hypertrophy (LVH).
  • Latent LVOTO (L-LVOTO) can be provoked by exertion and may occur in patients without LVH (non-LVH).
  • The prevalence and prognosis of L-LVOTO in non-LVH patients remain unclear.

Purpose of the Study:

  • To investigate echocardiographic features of L-LVOTO in non-LVH patients with malignancy.
  • To identify predictors of L-LVOTO in this patient cohort.
  • To evaluate the utility of dobutamine stress echocardiography (DSE) for detecting L-LVOTO.

Main Methods:

  • Retrospective analysis of 199 patients with malignancy, without LVH or coronary artery disease, who underwent DSE.
  • Comparison of baseline echocardiographic features between patients with and without L-LVOTO post-DSE.
  • Calculation of the left ventricular outflow tract (LVOT) ratio (systolic/diastolic diameter) as a potential predictor.

Main Results:

  • 106 out of 199 patients (53.3%) developed L-LVOTO after DSE.
  • A baseline LVOT ratio ≤ 0.83 was identified as a significant predictor of L-LVOTO (sensitivity 81.1%, specificity 80.6%).
  • The LVOT ratio strongly correlated with the presence of L-LVOTO in non-LVH patients.

Conclusions:

  • L-LVOTO is prevalent in nearly half of non-LVH patients with malignancy.
  • The baseline LVOT ratio is a reliable indicator for detecting L-LVOTO in this population.
  • DSE is valuable for identifying dynamic LVOT narrowing and L-LVOTO in non-LVH patients.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...